Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial.
Carlo SalvaraniMarco MassariMassimo CostantiniDomenico Franco MerloGabriella Lucia MarianiPierluigi VialeStefano NavaGiovanni GuaraldiGiovanni DolciLuca BoniLuisa SavoldiPaolo BruzziCaterina TurràMariagrazia CatanosoAnna Maria MarataChiara BarbieriAnnamaria ValcaviFrancesca FranzoniSilvio CavutoGiorgio MazziRomina CorsiniFabio TrapaniAlessandro BartoloniEmanuela BarisioneChiara BarbieriGiulia Jole BurasteroAngelo PanWalter InojosaRaffaele ScalaCecilia BurattiniFabrizio LuppiMauro CodeluppiKamal Eldin TarekGiovanni CenderelloMario SalioGiuseppe FotiRoberto DongilliGianluigi BajocchiEmanuele Alberto NegriGiacomo CiusaGiacomo FornaroIlaria BassiLorenzo ZammarchiTeresita AloèNicola FacciolongoPublished in: The European respiratory journal (2022)
Methylprenisolone pulse therapy added to dexamethasone was not of benefit in patients with COVID-19 pneumonia.